CN119497719A - Serpin肽衍生物及其使用方法 - Google Patents
Serpin肽衍生物及其使用方法 Download PDFInfo
- Publication number
- CN119497719A CN119497719A CN202380042370.9A CN202380042370A CN119497719A CN 119497719 A CN119497719 A CN 119497719A CN 202380042370 A CN202380042370 A CN 202380042370A CN 119497719 A CN119497719 A CN 119497719A
- Authority
- CN
- China
- Prior art keywords
- amino acid
- peptide derivative
- serpin
- serpin peptide
- core sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263363840P | 2022-04-29 | 2022-04-29 | |
| US63/363,840 | 2022-04-29 | ||
| PCT/US2023/066321 WO2023212661A1 (en) | 2022-04-29 | 2023-04-27 | Serpin peptide derivatives and methods of using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN119497719A true CN119497719A (zh) | 2025-02-21 |
Family
ID=88519894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380042370.9A Pending CN119497719A (zh) | 2022-04-29 | 2023-04-27 | Serpin肽衍生物及其使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250353898A1 (https=) |
| EP (1) | EP4514838A1 (https=) |
| JP (1) | JP2025515349A (https=) |
| CN (1) | CN119497719A (https=) |
| AU (1) | AU2023260921A1 (https=) |
| CA (1) | CA3256966A1 (https=) |
| IL (1) | IL316583A (https=) |
| MX (1) | MX2024013323A (https=) |
| WO (1) | WO2023212661A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439829A (en) * | 1991-01-30 | 1995-08-08 | Eli Lilly And Company | Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion |
| GB0916578D0 (en) * | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| CN102731626B (zh) * | 2011-04-13 | 2014-10-01 | 中国人民解放军军事医学科学院毒物药物研究所 | 环肽及其医药用途 |
| CA3077804C (en) * | 2012-01-09 | 2023-07-25 | Serpin Pharma, Llc | Peptides and methods of using same |
| WO2013172954A1 (en) * | 2012-05-17 | 2013-11-21 | Ra Pharmaceuticals, Inc | Peptide and peptidomimetic inhibitors |
| WO2016154041A1 (en) * | 2015-03-20 | 2016-09-29 | University Of Florida Research Foundation Incorporated | Serpin reactive center loop peptides and methods of use |
| WO2021219896A1 (en) * | 2020-05-01 | 2021-11-04 | Atlas Biotechnology S.A. | Treatment and/or prevention of a disease or a syndrome related to a virus infection |
| EP4003391A4 (en) * | 2020-07-06 | 2023-02-22 | Serpin Pharma, LLC | PEPTIDES AND METHODS OF USE THEREOF |
-
2023
- 2023-04-27 AU AU2023260921A patent/AU2023260921A1/en active Pending
- 2023-04-27 IL IL316583A patent/IL316583A/en unknown
- 2023-04-27 WO PCT/US2023/066321 patent/WO2023212661A1/en not_active Ceased
- 2023-04-27 JP JP2024563519A patent/JP2025515349A/ja active Pending
- 2023-04-27 US US18/861,168 patent/US20250353898A1/en active Pending
- 2023-04-27 CA CA3256966A patent/CA3256966A1/en active Pending
- 2023-04-27 EP EP23797555.2A patent/EP4514838A1/en active Pending
- 2023-04-27 CN CN202380042370.9A patent/CN119497719A/zh active Pending
-
2024
- 2024-10-28 MX MX2024013323A patent/MX2024013323A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4514838A1 (en) | 2025-03-05 |
| WO2023212661A1 (en) | 2023-11-02 |
| US20250353898A1 (en) | 2025-11-20 |
| AU2023260921A1 (en) | 2024-11-07 |
| CA3256966A1 (en) | 2023-11-02 |
| MX2024013323A (es) | 2024-12-06 |
| JP2025515349A (ja) | 2025-05-14 |
| IL316583A (en) | 2024-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240261364A1 (en) | Peptides and methods of using the same | |
| EP3368678A1 (en) | Genetic construct | |
| CN104427993B (zh) | 用于治疗由缺氧和低气压造成的肺型高山病的药物组合物 | |
| CN103476933A (zh) | 白介素1受体的拮抗剂 | |
| US10716825B2 (en) | Method of treating a liver disease comprising administering ostreolysin orfunctionally related variant thereof | |
| KR101399175B1 (ko) | 항염증성 및 항알레르기성 시클릭 펩티드 | |
| CN102205114B (zh) | 促红细胞生成素来源肽在制备治疗神经系统自身免疫性疾病的药物中的应用 | |
| CN104277092A (zh) | 用于预防和/或治疗老年性痴呆的β片层阻断肽 | |
| CN119497719A (zh) | Serpin肽衍生物及其使用方法 | |
| HK40121727A (zh) | Serpin肽衍生物及其使用方法 | |
| KR102772298B1 (ko) | 미엘린 장애의 치료를 위한 조성물 및 방법 | |
| KR20230160876A (ko) | 뇌 손상의 복합 치료 | |
| US20250161419A1 (en) | Serpin peptides and methods of using the same | |
| JP4778507B2 (ja) | 化学療法誘発末梢性ニューロパシーの治療のためのil6r/il6キメラ | |
| US20080311103A1 (en) | Anti-Inflammatory Peptides and Methods of Use Thereof | |
| HK40118659A (zh) | Serpin肽及其使用方法 | |
| WO2025137160A1 (en) | Cc16-derived analogs for the treatment of inflammatory and obstructive lung diseases | |
| US20050164909A1 (en) | Methods and reagents for treating inflammation and fibrosis | |
| KR20240086733A (ko) | 병인성 비멘틴 발현 유도를 통한 코로나바이러스 감염병 동반 전신경화증 모델 플랫폼 | |
| Neal | Prokineticin-2: a novel anti-apoptotic and anti-inflammatory signaling protein in Parkinson’s disease | |
| HK1246651B (en) | Ostreolysin for use in the treatment of steatohepatitis | |
| HK1247102A1 (zh) | 用於治療衰老相關病症的方法和組合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40121727 Country of ref document: HK |